Betta Pharmaceuticals Co (SZSE:300558) Operating Cash Flow per Share : ¥2.41 (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Operating Cash Flow per Share?

Betta Pharmaceuticals Co's operating cash flow per share for the three months ended in Mar. 2024 was ¥0.58. Betta Pharmaceuticals Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.41.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Betta Pharmaceuticals Co was 143.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 11.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Betta Pharmaceuticals Co's Operating Cash Flow per Share or its related term are showing as below:

SZSE:300558' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -18.7 Med: 9.15 Max: 31.9
Current: 11.2

During the past 13 years, Betta Pharmaceuticals Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 31.90% per year. The lowest was -18.70% per year. And the median was 9.15% per year.

SZSE:300558's 3-Year OCF Growth Rate is ranked better than
55.06% of 801 companies
in the Drug Manufacturers industry
Industry Median: 7.1 vs SZSE:300558: 11.20

Betta Pharmaceuticals Co Operating Cash Flow per Share Historical Data

The historical data trend for Betta Pharmaceuticals Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Operating Cash Flow per Share Chart

Betta Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.37

1.59

1.27

0.74

2.18

Betta Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.32	0.53	0.47	0.83	0.58

Competitive Comparison of Betta Pharmaceuticals Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's Price-to-Operating-Cash-Flow falls into.

Betta Pharmaceuticals Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Betta Pharmaceuticals Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	914.228	/	419.316
	=	2.18

Betta Pharmaceuticals Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	247.236	/	426.699
	=	0.58

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.41

Betta Pharmaceuticals Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.bettapharma.com

Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.

Executives

Wang Jia Bing	Directors, executives
Ding Lie Ming	Directors, executives
Cai Wan Yu	Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines